VTV Therapeutics Inc. Class AVTVT
13F holders, Q3 2025 (September 30)23holders +2
3new positions
1sold out
1famous investor
$23.33avg. 13F price*
At the end of Q3 2025, 23 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, up 2 from Q2 2025. 3 opened new positions and 1 sold out. The largest holders were Samsara Biocapital, LLC ($8.7M), FMR LLC ($4.5M) and Siren, L.L.C. ($3.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3.8M |
| Exits | 1 | $15 |
All 13F filers, Q2 2025 → Q3 2025: 404,470 shares bought and 3,334 shares sold, net +401,136 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Samsara Biocapital, LLC | 1.14% | Add +81.1% | 374,461 | $8.7M |
| FMR LLC | 0.00% | Add +8.2% | 192,891 | $4.5M |
| Siren, L.L.C. | 0.15% | New | 163,000 | $3.8M |
| Baker Bros. Advisors LP | 0.03% | Add +52.4% | 148,314 | $3.5M |
| Vanguard Group Inc. | 0.00% | Add +8.8% | 46,990 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +18.9% | 15,298 | $356K |
| Northern Trust Corp. | 0.00% | Reduce -8.0% | 14,072 | $329K |
| Millennium Management | 0.00% | Reduce -14.0% | 12,935 | $301K |
| Connective Capital Management, LLC | 0.21% | No change | 9,712 | $227K |
| BlackRock, Inc. | 0.00% | Add +2.2% | 4,935 | $115K |
| UBS Group AG | 0.00% | Add +4.3% | 2,970 | $69K |
| Osaic Holdings, Inc. | 0.00% | Add +852.9% | 1,620 | $37K |
| Morgan Stanley | 0.00% | No change | 746 | $17K |
| Strengthening Families & Communities, LLC | 0.00% | New | 173 | $4K |
| Activest Wealth Management | 0.00% | No change | 50 | $1K |
| CoreCap Advisors, LLC | 0.00% | No change | 45 | $1K |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $887 |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $350 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $210 |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $47 |
| Bank of America Corp. | 0.00% | Reduce -91.7% | 1 | $23 |
| Citigroup Inc. | 0.00% | New | 1 | $23 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 1 | $23 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.